Search Results - "Flotte, T"

Refine Results
  1. 1

    Clinical gene therapy using recombinant adeno-associated virus vectors by Mueller, C, Flotte, T R

    Published in Gene therapy (01-06-2008)
    “…Recombinant adeno-associated virus (rAAV) vectors possess a number of properties that may make them suitable for clinical gene therapy, including being based…”
    Get full text
    Journal Article
  2. 2

    Gene Therapy 2017: Progress and Future Directions by Keeler, AM, ElMallah, MK, Flotte, TR

    Published in Clinical and translational science (01-07-2017)
    “…[...]because CD19 is a pan‐B cell marker, one side effect is normal B‐cell depletion. [...]to try and restrict normal B‐cell depletion after CAR‐T cell…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors by SONG, S, EMBURY, J, LAIPIS, P. J, BERNS, K. I, CRAWFORD, J. M, FLOTTE, T. R

    Published in Gene therapy (01-09-2001)
    “…Previous work from our group showed that recombinant adeno-associated virus (rAAV) vectors mediated long-term secretion of therapeutic serum levels of human…”
    Get full text
    Journal Article
  6. 6

    Targeting recombinant adeno-associated virus vectors to enhance gene transfer to pancreatic islets and liver by LOILER, S. A, CONLON, T. J, MUZYCZKA, N, FLOTTE, T. R, SONG, S, TANG, Q, WARRINGTON, K. H, AGARWAL, A, KAPTURCZAK, M, LI, C, RICORDI, C, ATKINSON, M. A

    Published in Gene therapy (01-09-2003)
    “…Human pancreatic islet cells and hepatocytes represent the two most likely target cells for genetic therapy of type I diabetes. However, limits to the…”
    Get full text
    Journal Article
  7. 7

    Pushing the envelope in the lung by Flotte, T R

    Published in Gene therapy (01-02-2011)
    “…Sendai virus (SeV) is a single-stranded RNA virus that naturally infects the airways of rodents very efciently, causing an acute respiratory illness. In a…”
    Get full text
    Journal Article
  8. 8

    IL-10 delivery by AAV5 vector attenuates inflammation in mice with pseudomonas pneumonia by Buff, S M, Yu, H, McCall, J N, Caldwell, S M, Ferkol, T W, Flotte, T R, Virella-Lowell, I L

    Published in Gene therapy (01-05-2010)
    “…Lung infections with Pseudomonas aeruginosa and other pathogens in cystic fibrosis (CF) cause progressive airway obstruction and tissue damage, the predominant…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Recombinant adeno-associated virus-mediated alpha-1 antitrypsin gene therapy prevents type I diabetes in NOD mice by SONG, S, GOUDY, K, FLOTTE, T. R, CAMPBELL-THOMPSON, M, WASSERFALL, C, SCOTT-JORGENSEN, M, WANG, J, TANG, Q, CRAWFORD, J. M, ELLIS, T. M, ATKINSON, M. A

    Published in Gene therapy (01-01-2004)
    “…Type I diabetes results from an autoimmune destruction of the insulin-producing pancreatic beta cells. Although the exact immunologic processes underlying this…”
    Get full text
    Journal Article
  11. 11

    Mutational Analysis of the Adeno-Associated Virus Type 2 (AAV2) Capsid Gene and Construction of AAV2 Vectors with Altered Tropism by Wu, Pei, Xiao, Wu, Conlon, Thomas, Hughes, Jeffrey, Agbandje-McKenna, Mavis, Ferkol, Thomas, Flotte, Terence, Muzyczka, Nicholas

    Published in Journal of Virology (01-09-2000)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  12. 12

    Progress and Prospects: Gene Therapy Clinical Trials (Part 1) by ALTON, Eric, BAINBRIDGE, J. W, GREZ, M, THRASHER, A. Z, OTT, M. G, SEGER, R, ALEXANDER, B. L, KAPLITT, M. G, SIMONS, M, YLÄ-HERTTUALA, S, ALL, R. R, GRIESENBACH, U, ALTON, E. W. F. W, FLOTTE, T. R, BRAUN, S, CHENG, S. H, THRASHER, A. J, GASPAR, H. B

    Published in Gene therapy (01-10-2007)
    “…Over the last two decades gene therapy has moved from preclinical to clinical studies for many diseases ranging from single gene disorders such as cystic…”
    Get full text
    Journal Article
  13. 13

    Dermal and conjunctival melanocytic proliferations in diffuse uveal melanocytic proliferation by Pulido, J S, Flotte, T J, Raja, H, Miles, S, Winters, J L, Niles, R, Jaben, E A, Markovic, S N, Davies, J, Kalli, K R, Vile, R G, Garcia, J J, Salomao, D R

    Published in Eye (London) (01-09-2013)
    “…Aim The goal of this case report is to describe the dermatologic and conjunctival findings in a case of bilateral diffuse uveal melanocytic proliferation…”
    Get full text
    Journal Article
  14. 14

    The pros and cons of immunomodulatory IL-10 gene therapy with recombinant AAV in a Cftr -dependent allergy mouse model by Mueller, C, Braag, S A, Martino, A T, Tang, Q, Campbell-Thompson, M, Flotte, T R

    Published in Gene therapy (01-02-2009)
    “…Cystic fibrosis (CF) patients have decreased levels of lung epithelial interleukin (IL)-10 and increased levels of proinflammatory cytokines (tumor necrosis…”
    Get full text
    Journal Article
  15. 15

    Gene therapy for alpha-1 antitrypsin deficiency by Flotte, Terence R, Mueller, Christian

    Published in Human molecular genetics (15-04-2011)
    “…Alpha-1 antitrypsin (AAT) deficiency is a common single-gene disorder among Northern Europeans and North Americans. The carrier frequency for the common…”
    Get full text
    Journal Article
  16. 16

    Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys by Kramer, M, Miller, J W, Michaud, N, Moulton, R S, Hasan, T, Flotte, T J, Gragoudas, E S

    Published in Ophthalmology (Rochester, Minn.) (01-03-1996)
    “…The authors have previously shown that photodynamic therapy (PDT) using lipoprotein-delivered benzoporphyrin derivative mono-acid (BPD) effectively closed…”
    Get more information
    Journal Article
  17. 17

    Adeno-associated virus vectors for gene therapy by Flotte, T R, Carter, B J

    Published in Gene therapy (1995)
    “…Adeno-associated virus type 2 (AAV) is a non-pathogenic DNA virus which has been utilized as a eukaryotic gene transfer vector in vitro and in vivo. AAV…”
    Get more information
    Journal Article
  18. 18

    Gene therapy in cystic fibrosis by Flotte, T R, Laube, B L

    Published in Chest (01-09-2001)
    “…Theoretically, cystic fibrosis transmembrane conductance regulator (CFTR) gene replacement during the neonatal period can decrease morbidity and mortality from…”
    Get more information
    Journal Article
  19. 19

    CMV-beta-actin promoter directs higher expression from an adeno-associated viral vector in the liver than the cytomegalovirus or elongation factor 1 alpha promoter and results in therapeutic levels of human factor X in mice by Xu, L, Daly, T, Gao, C, Flotte, T R, Song, S, Byrne, B J, Sands, M S, Parker Ponder, K

    Published in Human gene therapy (20-03-2001)
    “…Although AAV vectors show promise for hepatic gene therapy, the optimal transcriptional regulatory elements have not yet been identified. In this study, we…”
    Get more information
    Journal Article
  20. 20

    Detection of microscopic melanoma metastases in sentinel lymph nodes by Yu, Lawrence L., Flotte, Thomas J., Tanabe, Kenneth K., Gadd, Michele A., Cosimi, A. Benedict, Sober, Arthur J., Mihm, Martin C., Duncan, Lyn M.

    Published in Cancer (15-08-1999)
    “…BACKGROUND Sentinel lymph node biopsy following radioisotope labeling is a recently developed, minimally invasive surgical staging procedure used in the…”
    Get full text
    Journal Article